Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
27001
27002
27003
27004
27005
27006
27007
27008
27009
27010
27011
27012
27013
27014
27015
27016
27017
27018
27019
27020
27021
27022
27023
27024
27025
27026
27027
27028
27029
27030
27031
27032
27033
27034
27035
27036
27037
27038
27039
27040
27041
27042
27043
27044
27045
27046
27047
27048
27049
27050
27051
27052
27053
27054
27055
27056
27057
27058
27059
27060
27061
27062
27063
27064
27065
27066
27067
27068
27069
27070
27071
27072
27073
27074
27075
27076
27077
27078
27079
27080
27081
27082
27083
27084
27085
27086
27087
27088
27089
27090
27091
27092
27093
27094
27095
27096
27097
27098
27099
27100
27101
27102
27103
27104
27105
27106
27107
27108
27109
27110
27111
27112
27113
27114
27115
27116
27117
27118
27119
27120
27121
27122
27123
27124
27125
27126
27127
27128
27129
27130
27131
27132
27133
27134
27135
27136
27137
27138
27139
27140
27141
27142
27143
27144
27145
27146
27147
27148
27149
27150
27151
27152
27153
27154
27155
27156
27157
27158
27159
27160
27161
27162
27163
27164
27165
27166
27167
27168
27169
27170
27171
27172
27173
27174
27175
27176
27177
27178
27179
27180
27181
27182
27183
27184
27185
27186
27187
27188
27189
27190
27191
27192
27193
27194
27195
27196
27197
27198
27199
27200
| UnnamedSample_HQ_transcript/22721|m.7623 | UnnamedSample_HQ_transcript/22721 | Coverage 0.272 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/30226|m.9529 | UnnamedSample_HQ_transcript/30226 | Coverage 0.318 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/21206|m.7200 | UnnamedSample_HQ_transcript/21206 | Coverage 0.272 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/5818|m.2465 | UnnamedSample_HQ_transcript/5818 | Coverage 0.192 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/32315|m.10034 | UnnamedSample_HQ_transcript/32315 | Coverage 0.244 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/30579|m.9604 | UnnamedSample_HQ_transcript/30579 | Coverage 0.305 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/38000|m.11394 | UnnamedSample_HQ_transcript/38000 | Coverage 0.330 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/7331|m.2961 | UnnamedSample_HQ_transcript/7331 | Coverage 0.162 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/17702|m.6224 | UnnamedSample_HQ_transcript/17702 | Coverage 0.256 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/24788|m.8162 | UnnamedSample_HQ_transcript/24788 | Coverage 0.297 too low. | 8b4ef369095a81b98e8954d94c59cb07 | 651 | Pfam | PF01532 | Glycosyl hydrolase family 47 | 197 | 637 | 1.2E-150 | T | 22-09-2020 | IPR001382 | Glycoside hydrolase family 47 |
| UnnamedSample_HQ_transcript/33497|m.10336 | UnnamedSample_HQ_transcript/33497 | Identity 0.854 too low. | 9ac554c8a1c84f9384fe1d821a2433d5 | 555 | Pfam | PF00176 | SNF2 family N-terminal domain | 44 | 224 | 6.4E-43 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/33497|m.10336 | UnnamedSample_HQ_transcript/33497 | Identity 0.854 too low. | 9ac554c8a1c84f9384fe1d821a2433d5 | 555 | Pfam | PF00271 | Helicase conserved C-terminal domain | 251 | 363 | 2.7E-20 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/108456|m.23640 | UnnamedSample_HQ_transcript/108456 | Coverage 0.277 too low. | a806e7058e3e23b3d4c0fe0f4392a333 | 251 | Pfam | PF00501 | AMP-binding enzyme | 11 | 153 | 1.6E-36 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/108456|m.23640 | UnnamedSample_HQ_transcript/108456 | Coverage 0.277 too low. | a806e7058e3e23b3d4c0fe0f4392a333 | 251 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 162 | 238 | 1.3E-17 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/12213|m.4562 | UnnamedSample_HQ_transcript/12213 | Identity 0.878 too low. | f9e5827fe96891da4cdfc0ce33a8778d | 845 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 610 | 667 | 1.2E-22 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/12213|m.4562 | UnnamedSample_HQ_transcript/12213 | Identity 0.878 too low. | f9e5827fe96891da4cdfc0ce33a8778d | 845 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 713 | 840 | 8.6E-18 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/11932|m.4477 | UnnamedSample_HQ_transcript/11932 | Coverage 0.124 too low. | 7679e6dfed4f7ab8b13058cbcfd94e10 | 532 | Pfam | PF00400 | WD domain, G-beta repeat | 384 | 411 | 0.24 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/11932|m.4477 | UnnamedSample_HQ_transcript/11932 | Coverage 0.124 too low. | 7679e6dfed4f7ab8b13058cbcfd94e10 | 532 | Pfam | PF00400 | WD domain, G-beta repeat | 226 | 271 | 1.3E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/11932|m.4477 | UnnamedSample_HQ_transcript/11932 | Coverage 0.124 too low. | 7679e6dfed4f7ab8b13058cbcfd94e10 | 532 | Pfam | PF03451 | HELP motif | 150 | 222 | 6.2E-32 | T | 22-09-2020 | IPR005108 | HELP |
| UnnamedSample_HQ_transcript/95645|m.22043 | UnnamedSample_HQ_transcript/95645 | Coverage 0.921 too low. | 1d3d43284f6d9e918f9b92d94a8714b2 | 352 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 10 | 45 | 9.7E-7 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/95645|m.22043 | UnnamedSample_HQ_transcript/95645 | Coverage 0.921 too low. | 1d3d43284f6d9e918f9b92d94a8714b2 | 352 | Pfam | PF00107 | Zinc-binding dehydrogenase | 107 | 236 | 8.4E-14 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/70411|m.18000 | UnnamedSample_HQ_transcript/70411 | Coverage 0.976 too low. | 6b223e9f221d56d44a8939e5304a4bc7 | 475 | Pfam | PF03165 | MH1 domain | 28 | 129 | 5.1E-20 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/106527|m.23399 | UnnamedSample_HQ_transcript/106527 | Coverage 0.946 too low. | a54e6ec31084bfc684fd75cc8a1ebb16 | 264 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 95 | 181 | 7.0E-23 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/90459|m.21322 | UnnamedSample_HQ_transcript/90459 | Identity 0.936 too low. | 2d6ee36aed71539e4cad93876b8a6d0b | 349 | Pfam | PF13895 | Immunoglobulin domain | 85 | 157 | 1.6E-6 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/24594|m.8101 | UnnamedSample_HQ_transcript/24594 | Coverage 0.822 too low. | 69717243168f64cc1c6f3f87e68d9236 | 626 | Pfam | PF07690 | Major Facilitator Superfamily | 105 | 262 | 2.9E-13 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/24594|m.8101 | UnnamedSample_HQ_transcript/24594 | Coverage 0.822 too low. | 69717243168f64cc1c6f3f87e68d9236 | 626 | Pfam | PF07690 | Major Facilitator Superfamily | 434 | 605 | 7.2E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/50130|m.14048 | UnnamedSample_HQ_transcript/50130 | Coverage 0.867 too low. | c5762f3592ca2aaf66ca3771e4c8a551 | 469 | Pfam | PF00169 | PH domain | 348 | 453 | 4.0E-6 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/50130|m.14048 | UnnamedSample_HQ_transcript/50130 | Coverage 0.867 too low. | c5762f3592ca2aaf66ca3771e4c8a551 | 469 | Pfam | PF00617 | RasGEF domain | 1 | 158 | 1.9E-47 | T | 22-09-2020 | IPR001895 | Ras guanine-nucleotide exchange factors catalytic domain |
| UnnamedSample_HQ_transcript/57389|m.15522 | UnnamedSample_HQ_transcript/57389 | Coverage 0.885 too low. | c5762f3592ca2aaf66ca3771e4c8a551 | 469 | Pfam | PF00169 | PH domain | 348 | 453 | 4.0E-6 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/57389|m.15522 | UnnamedSample_HQ_transcript/57389 | Coverage 0.885 too low. | c5762f3592ca2aaf66ca3771e4c8a551 | 469 | Pfam | PF00617 | RasGEF domain | 1 | 158 | 1.9E-47 | T | 22-09-2020 | IPR001895 | Ras guanine-nucleotide exchange factors catalytic domain |
| UnnamedSample_HQ_transcript/77345|m.19267 | UnnamedSample_HQ_transcript/77345 | Coverage 0.865 too low. | 2a3773bc494c941bf236b4160674e7b8 | 472 | Pfam | PF11598 | Cartilage oligomeric matrix protein | 216 | 256 | 6.1E-8 | T | 22-09-2020 | IPR024665 | Thrombospondin/cartilage oligomeric matrix protein, coiled-coil domain |
| UnnamedSample_HQ_transcript/41149|m.12089 | UnnamedSample_HQ_transcript/41149 | Identity 0.902 too low. | 60e382096b444354e0efcdd23beb8b87 | 659 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 34 | 589 | 2.6E-204 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 2044 | 2129 | 2.0E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 805 | 892 | 4.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1483 | 1565 | 2.1E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 517 | 607 | 9.0E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1091 | 1181 | 6.1E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 614 | 697 | 1.9E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 998 | 1084 | 1.0E-19 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1662 | 1748 | 1.2E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 2171 | 2259 | 7.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 709 | 797 | 1.4E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 318 | 410 | 1.4E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1291 | 1370 | 1.4E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1765 | 1846 | 4.3E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 418 | 510 | 8.9E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 900 | 990 | 2.4E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1419 | 1473 | 2.5E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1188 | 1279 | 3.0E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1857 | 1941 | 5.5E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1963 | 2035 | 1.8E-6 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00307 | Calponin homology (CH) domain | 81 | 184 | 5.2E-22 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/292|m.240 | UnnamedSample_HQ_transcript/292 | Coverage 0.569 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00307 | Calponin homology (CH) domain | 207 | 304 | 1.0E-12 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 2044 | 2129 | 2.0E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 805 | 892 | 4.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1483 | 1565 | 2.1E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 517 | 607 | 9.0E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1091 | 1181 | 6.1E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 614 | 697 | 1.9E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 998 | 1084 | 1.0E-19 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1662 | 1748 | 1.2E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 2171 | 2259 | 7.8E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 709 | 797 | 1.4E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 318 | 410 | 1.4E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1291 | 1370 | 1.4E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1765 | 1846 | 4.3E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 418 | 510 | 8.9E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 900 | 990 | 2.4E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1419 | 1473 | 2.5E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1188 | 1279 | 3.0E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1857 | 1941 | 5.5E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00630 | Filamin/ABP280 repeat | 1963 | 2035 | 1.8E-6 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00307 | Calponin homology (CH) domain | 81 | 184 | 5.2E-22 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/344|m.267 | UnnamedSample_HQ_transcript/344 | Coverage 0.584 too low. | 02e6bc62ca503f284f02e8d15e8745ce | 2262 | Pfam | PF00307 | Calponin homology (CH) domain | 207 | 304 | 1.0E-12 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/65826|m.17169 | UnnamedSample_HQ_transcript/65826 | Coverage 0.705 too low. | 492fd14e0728c27e814431854e4fb443 | 427 | Pfam | PF00651 | BTB/POZ domain | 23 | 117 | 1.3E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/85880|m.20634 | UnnamedSample_HQ_transcript/85880 | Coverage 0.928 too low. | eba97c3cd294fa3c361f3c86081a3cb8 | 335 | Pfam | PF00651 | BTB/POZ domain | 164 | 268 | 6.7E-30 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/50902|m.14226 | UnnamedSample_HQ_transcript/50902 | Coverage 0.876 too low. | edb497bc6398942f6d4e93db96ee4e6d | 569 | Pfam | PF02770 | Acyl-CoA dehydrogenase, middle domain | 29 | 139 | 1.1E-13 | T | 22-09-2020 | IPR006091 | Acyl-CoA oxidase/dehydrogenase, central domain |
| UnnamedSample_HQ_transcript/50902|m.14226 | UnnamedSample_HQ_transcript/50902 | Coverage 0.876 too low. | edb497bc6398942f6d4e93db96ee4e6d | 569 | Pfam | PF01756 | Acyl-CoA oxidase | 386 | 562 | 8.0E-45 | T | 22-09-2020 | IPR002655 | Acyl-CoA oxidase, C-terminal |
| UnnamedSample_HQ_transcript/61155|m.16294 | UnnamedSample_HQ_transcript/61155 | Coverage 0.664 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 231 | 302 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/61155|m.16294 | UnnamedSample_HQ_transcript/61155 | Coverage 0.664 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 383 | 454 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/61155|m.16294 | UnnamedSample_HQ_transcript/61155 | Coverage 0.664 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 3 | 74 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/61155|m.16294 | UnnamedSample_HQ_transcript/61155 | Coverage 0.664 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 155 | 226 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/61155|m.16294 | UnnamedSample_HQ_transcript/61155 | Coverage 0.664 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 307 | 378 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/61155|m.16294 | UnnamedSample_HQ_transcript/61155 | Coverage 0.664 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 459 | 530 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/61155|m.16294 | UnnamedSample_HQ_transcript/61155 | Coverage 0.664 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 79 | 150 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/60452|m.16155 | UnnamedSample_HQ_transcript/60452 | Coverage 0.737 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 231 | 302 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/60452|m.16155 | UnnamedSample_HQ_transcript/60452 | Coverage 0.737 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 383 | 454 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/60452|m.16155 | UnnamedSample_HQ_transcript/60452 | Coverage 0.737 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 3 | 74 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/60452|m.16155 | UnnamedSample_HQ_transcript/60452 | Coverage 0.737 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 155 | 226 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/60452|m.16155 | UnnamedSample_HQ_transcript/60452 | Coverage 0.737 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 307 | 378 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/60452|m.16155 | UnnamedSample_HQ_transcript/60452 | Coverage 0.737 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 459 | 530 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/60452|m.16155 | UnnamedSample_HQ_transcript/60452 | Coverage 0.737 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 79 | 150 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/63473|m.16727 | UnnamedSample_HQ_transcript/63473 | Coverage 0.731 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 231 | 302 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/63473|m.16727 | UnnamedSample_HQ_transcript/63473 | Coverage 0.731 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 383 | 454 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/63473|m.16727 | UnnamedSample_HQ_transcript/63473 | Coverage 0.731 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 3 | 74 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/63473|m.16727 | UnnamedSample_HQ_transcript/63473 | Coverage 0.731 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 155 | 226 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/63473|m.16727 | UnnamedSample_HQ_transcript/63473 | Coverage 0.731 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 307 | 378 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/63473|m.16727 | UnnamedSample_HQ_transcript/63473 | Coverage 0.731 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 459 | 530 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/63473|m.16727 | UnnamedSample_HQ_transcript/63473 | Coverage 0.731 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 79 | 150 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/64999|m.17027 | UnnamedSample_HQ_transcript/64999 | Coverage 0.655 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 231 | 302 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/64999|m.17027 | UnnamedSample_HQ_transcript/64999 | Coverage 0.655 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 383 | 454 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/64999|m.17027 | UnnamedSample_HQ_transcript/64999 | Coverage 0.655 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 3 | 74 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/64999|m.17027 | UnnamedSample_HQ_transcript/64999 | Coverage 0.655 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 155 | 226 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/64999|m.17027 | UnnamedSample_HQ_transcript/64999 | Coverage 0.655 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 307 | 378 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/64999|m.17027 | UnnamedSample_HQ_transcript/64999 | Coverage 0.655 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 459 | 530 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/64999|m.17027 | UnnamedSample_HQ_transcript/64999 | Coverage 0.655 too low. | a248a7076fbfe7cd4f0286d0788dbd7b | 533 | Pfam | PF00240 | Ubiquitin family | 79 | 150 | 2.4E-33 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/70349|m.17990 | UnnamedSample_HQ_transcript/70349 | Coverage 0.672 too low. | b307a3f6de98862d386e8aedd7b0cd64 | 339 | Pfam | PF00554 | Rel homology DNA-binding domain | 174 | 334 | 1.1E-28 | T | 22-09-2020 | IPR011539 | Rel homology domain (RHD), DNA-binding domain |
| UnnamedSample_HQ_transcript/1316|m.772 | UnnamedSample_HQ_transcript/1316 | Coverage 0.089 too low. | 479edad959b744b259912ca9b61b81cf | 749 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 76 | 443 | 4.5E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/1316|m.772 | UnnamedSample_HQ_transcript/1316 | Coverage 0.089 too low. | 479edad959b744b259912ca9b61b81cf | 749 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 513 | 716 | 1.6E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/1316|m.772 | UnnamedSample_HQ_transcript/1316 | Coverage 0.089 too low. | 479edad959b744b259912ca9b61b81cf | 749 | Pfam | PF00122 | E1-E2 ATPase | 18 | 58 | 1.5E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2753|m.1342 | UnnamedSample_HQ_transcript/2753 | Coverage 0.068 too low. | 0aa6ef02bd93e3eaf6837789dfe55baa | 1587 | Pfam | PF00501 | AMP-binding enzyme | 981 | 1426 | 6.1E-59 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/2753|m.1342 | UnnamedSample_HQ_transcript/2753 | Coverage 0.068 too low. | 0aa6ef02bd93e3eaf6837789dfe55baa | 1587 | Pfam | PF00501 | AMP-binding enzyme | 347 | 796 | 6.5E-33 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/2753|m.1342 | UnnamedSample_HQ_transcript/2753 | Coverage 0.068 too low. | 0aa6ef02bd93e3eaf6837789dfe55baa | 1587 | Pfam | PF06464 | DMAP1-binding Domain | 9 | 70 | 5.3E-16 | T | 22-09-2020 | IPR010506 | DMAP1-binding domain |
| UnnamedSample_HQ_transcript/44844|m.12878 | UnnamedSample_HQ_transcript/44844 | Identity 0.946 too low. | 963991ccda09a9cd69ae8c83179cd8e1 | 545 | Pfam | PF09820 | Predicted AAA-ATPase | 1 | 232 | 9.8E-32 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/3833|m.1749 | UnnamedSample_HQ_transcript/3833 | Coverage 0.739 too low. | a366444c9f941b1b6365e12346151122 | 1588 | Pfam | PF00595 | PDZ domain | 1043 | 1123 | 8.1E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/3833|m.1749 | UnnamedSample_HQ_transcript/3833 | Coverage 0.739 too low. | a366444c9f941b1b6365e12346151122 | 1588 | Pfam | PF01843 | DIL domain | 813 | 915 | 2.7E-30 | T | 22-09-2020 | IPR002710 | Dilute domain |
| UnnamedSample_HQ_transcript/3833|m.1749 | UnnamedSample_HQ_transcript/3833 | Coverage 0.739 too low. | a366444c9f941b1b6365e12346151122 | 1588 | Pfam | PF00498 | FHA domain | 428 | 485 | 3.3E-6 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/3833|m.1749 | UnnamedSample_HQ_transcript/3833 | Coverage 0.739 too low. | a366444c9f941b1b6365e12346151122 | 1588 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 239 | 349 | 1.0E-20 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/3833|m.1749 | UnnamedSample_HQ_transcript/3833 | Coverage 0.739 too low. | a366444c9f941b1b6365e12346151122 | 1588 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 45 | 136 | 2.9E-19 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/35035|m.10726 | UnnamedSample_HQ_transcript/35035 | Coverage 0.351 too low. | 390671cc3db0accd4e97ec281b9e858e | 600 | Pfam | PF00849 | RNA pseudouridylate synthase | 245 | 393 | 1.4E-29 | T | 22-09-2020 | IPR006145 | Pseudouridine synthase, RsuA/RluA |
| UnnamedSample_HQ_transcript/38414|m.11486 | UnnamedSample_HQ_transcript/38414 | Coverage 0.330 too low. | 390671cc3db0accd4e97ec281b9e858e | 600 | Pfam | PF00849 | RNA pseudouridylate synthase | 245 | 393 | 1.4E-29 | T | 22-09-2020 | IPR006145 | Pseudouridine synthase, RsuA/RluA |
| UnnamedSample_HQ_transcript/32642|m.10123 | UnnamedSample_HQ_transcript/32642 | Coverage 0.372 too low. | 390671cc3db0accd4e97ec281b9e858e | 600 | Pfam | PF00849 | RNA pseudouridylate synthase | 245 | 393 | 1.4E-29 | T | 22-09-2020 | IPR006145 | Pseudouridine synthase, RsuA/RluA |
| UnnamedSample_HQ_transcript/31474|m.9826 | UnnamedSample_HQ_transcript/31474 | Coverage 0.382 too low. | 390671cc3db0accd4e97ec281b9e858e | 600 | Pfam | PF00849 | RNA pseudouridylate synthase | 245 | 393 | 1.4E-29 | T | 22-09-2020 | IPR006145 | Pseudouridine synthase, RsuA/RluA |
| UnnamedSample_HQ_transcript/27801|m.8917 | UnnamedSample_HQ_transcript/27801 | Coverage 0.946 too low. | 16f4b1e2e24730a5603fe806ac833b2e | 269 | Pfam | PF00245 | Alkaline phosphatase | 58 | 261 | 2.5E-48 | T | 22-09-2020 | IPR001952 | Alkaline phosphatase |
| UnnamedSample_HQ_transcript/14214|m.5177 | UnnamedSample_HQ_transcript/14214 | Coverage 0.910 too low. | a986ee9aa3c37da30791e3b9489e91d9 | 628 | Pfam | PF13193 | AMP-binding enzyme C-terminal domain | 506 | 580 | 6.4E-6 | T | 22-09-2020 | IPR025110 | AMP-binding enzyme, C-terminal domain |
| UnnamedSample_HQ_transcript/14214|m.5177 | UnnamedSample_HQ_transcript/14214 | Coverage 0.910 too low. | a986ee9aa3c37da30791e3b9489e91d9 | 628 | Pfam | PF00501 | AMP-binding enzyme | 66 | 497 | 7.4E-72 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/37280|m.11227 | UnnamedSample_HQ_transcript/37280 | Unmapped. | 83d728ce6e49827eb0fbbf0cc5fb4f72 | 824 | Pfam | PF13087 | AAA domain | 584 | 755 | 5.4E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/37280|m.11227 | UnnamedSample_HQ_transcript/37280 | Unmapped. | 83d728ce6e49827eb0fbbf0cc5fb4f72 | 824 | Pfam | PF13086 | AAA domain | 401 | 470 | 3.6E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/38624|m.11537 | UnnamedSample_HQ_transcript/38624 | Coverage 0.689 too low. | 003167596fc2350ced4716c41999d0aa | 548 | Pfam | PF00611 | Fes/CIP4, and EFC/F-BAR homology domain | 14 | 87 | 2.7E-13 | T | 22-09-2020 | IPR001060 | FCH domain |
| UnnamedSample_HQ_transcript/38624|m.11537 | UnnamedSample_HQ_transcript/38624 | Coverage 0.689 too low. | 003167596fc2350ced4716c41999d0aa | 548 | Pfam | PF00018 | SH3 domain | 496 | 541 | 6.0E-13 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/18288|m.6391 | UnnamedSample_HQ_transcript/18288 | Coverage 0.889 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.5E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18288|m.6391 | UnnamedSample_HQ_transcript/18288 | Coverage 0.889 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.6E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18288|m.6391 | UnnamedSample_HQ_transcript/18288 | Coverage 0.889 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.2E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/18288|m.6391 | UnnamedSample_HQ_transcript/18288 | Coverage 0.889 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 6.7E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/18288|m.6391 | UnnamedSample_HQ_transcript/18288 | Coverage 0.889 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 6.7E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/18288|m.6391 | UnnamedSample_HQ_transcript/18288 | Coverage 0.889 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 9.7E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/18288|m.6391 | UnnamedSample_HQ_transcript/18288 | Coverage 0.889 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.1E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/21480|m.7274 | UnnamedSample_HQ_transcript/21480 | Coverage 0.882 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.5E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21480|m.7274 | UnnamedSample_HQ_transcript/21480 | Coverage 0.882 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.6E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21480|m.7274 | UnnamedSample_HQ_transcript/21480 | Coverage 0.882 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.2E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/21480|m.7274 | UnnamedSample_HQ_transcript/21480 | Coverage 0.882 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 6.7E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/21480|m.7274 | UnnamedSample_HQ_transcript/21480 | Coverage 0.882 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 6.7E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/21480|m.7274 | UnnamedSample_HQ_transcript/21480 | Coverage 0.882 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 9.7E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/21480|m.7274 | UnnamedSample_HQ_transcript/21480 | Coverage 0.882 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.1E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/33345|m.10299 | UnnamedSample_HQ_transcript/33345 | Coverage 0.859 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.5E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/33345|m.10299 | UnnamedSample_HQ_transcript/33345 | Coverage 0.859 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.6E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/33345|m.10299 | UnnamedSample_HQ_transcript/33345 | Coverage 0.859 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.2E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/33345|m.10299 | UnnamedSample_HQ_transcript/33345 | Coverage 0.859 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 6.7E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/33345|m.10299 | UnnamedSample_HQ_transcript/33345 | Coverage 0.859 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 6.7E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/33345|m.10299 | UnnamedSample_HQ_transcript/33345 | Coverage 0.859 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 9.7E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/33345|m.10299 | UnnamedSample_HQ_transcript/33345 | Coverage 0.859 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.1E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/14211|m.5176 | UnnamedSample_HQ_transcript/14211 | Coverage 0.894 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.5E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/14211|m.5176 | UnnamedSample_HQ_transcript/14211 | Coverage 0.894 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.6E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/14211|m.5176 | UnnamedSample_HQ_transcript/14211 | Coverage 0.894 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.2E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/14211|m.5176 | UnnamedSample_HQ_transcript/14211 | Coverage 0.894 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 6.7E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/14211|m.5176 | UnnamedSample_HQ_transcript/14211 | Coverage 0.894 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 6.7E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/14211|m.5176 | UnnamedSample_HQ_transcript/14211 | Coverage 0.894 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 9.7E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/14211|m.5176 | UnnamedSample_HQ_transcript/14211 | Coverage 0.894 too low. | 32cc52fb2f066c4cadeafd78080904c6 | 750 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.1E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/108521|m.23647 | UnnamedSample_HQ_transcript/108521 | Coverage 0.105 too low. | 82df4b89deaa142f1c322ed2bf07b3d7 | 237 | Pfam | PF00098 | Zinc knuckle | 102 | 116 | 2.2E-5 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/41089|m.12082 | UnnamedSample_HQ_transcript/41089 | Identity 0.938 too low. | 47be9cec74a87ea8f5c77e7b85aa3c29 | 531 | Pfam | PF00069 | Protein kinase domain | 164 | 477 | 3.5E-53 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/37471|m.11265 | UnnamedSample_HQ_transcript/37471 | Identity 0.940 too low. | 47be9cec74a87ea8f5c77e7b85aa3c29 | 531 | Pfam | PF00069 | Protein kinase domain | 164 | 477 | 3.5E-53 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/34476|m.10600 | UnnamedSample_HQ_transcript/34476 | Identity 0.942 too low. | 47be9cec74a87ea8f5c77e7b85aa3c29 | 531 | Pfam | PF00069 | Protein kinase domain | 164 | 477 | 3.5E-53 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/35609|m.10841 | UnnamedSample_HQ_transcript/35609 | Identity 0.942 too low. | 47be9cec74a87ea8f5c77e7b85aa3c29 | 531 | Pfam | PF00069 | Protein kinase domain | 164 | 477 | 3.5E-53 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/36776|m.11109 | UnnamedSample_HQ_transcript/36776 | Coverage 0.936 too low. | d490105022228d40e14055e7318f8749 | 816 | Pfam | PF02732 | ERCC4 domain | 571 | 699 | 1.1E-19 | T | 22-09-2020 | IPR006166 | ERCC4 domain |
| UnnamedSample_HQ_transcript/105979|m.23332 | UnnamedSample_HQ_transcript/105979 | Identity 0.938 too low. | 95707ec3248f1b10a3aed9c104cbd300 | 175 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 72 | 141 | 2.9E-14 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/12408|m.4624 | UnnamedSample_HQ_transcript/12408 | Identity 0.762 too low. | d7fa477b795813ba9f385947682494af | 497 | Pfam | PF12448 | Kinesin associated protein | 92 | 236 | 1.0E-20 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/10582|m.4016 | UnnamedSample_HQ_transcript/10582 | Identity 0.773 too low. | d7fa477b795813ba9f385947682494af | 497 | Pfam | PF12448 | Kinesin associated protein | 92 | 236 | 1.0E-20 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/42622|m.12398 | UnnamedSample_HQ_transcript/42622 | Unmapped. | e873411cf78cb32b863bfc008022171e | 727 | Pfam | PF00910 | RNA helicase | 242 | 350 | 2.0E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/104796|m.23207 | UnnamedSample_HQ_transcript/104796 | Coverage 0.918 too low. | 51158959e3f7d3e7ab9f8eb7b11b6306 | 277 | Pfam | PF01778 | Ribosomal L28e protein family | 6 | 118 | 2.7E-35 | T | 22-09-2020 | IPR029004 | Ribosomal L28e/Mak16 |
| UnnamedSample_HQ_transcript/104796|m.23207 | UnnamedSample_HQ_transcript/104796 | Coverage 0.918 too low. | 51158959e3f7d3e7ab9f8eb7b11b6306 | 277 | Pfam | PF04874 | Mak16 protein C-terminal region | 137 | 233 | 3.5E-22 | T | 22-09-2020 | IPR006958 | Mak16 protein |
| UnnamedSample_HQ_transcript/17518|m.6163 | UnnamedSample_HQ_transcript/17518 | Coverage 0.891 too low. | 7721cf96358e8560a23784de0dd54a14 | 429 | Pfam | PF07690 | Major Facilitator Superfamily | 85 | 409 | 1.8E-23 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/100918|m.22745 | UnnamedSample_HQ_transcript/100918 | Coverage 0.430 too low. | b9c84e756a94d81c19478956b5e0c000 | 283 | Pfam | PF00626 | Gelsolin repeat | 193 | 268 | 2.9E-12 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/100918|m.22745 | UnnamedSample_HQ_transcript/100918 | Coverage 0.430 too low. | b9c84e756a94d81c19478956b5e0c000 | 283 | Pfam | PF00626 | Gelsolin repeat | 80 | 157 | 1.4E-5 | T | 22-09-2020 | IPR007123 | Gelsolin-like domain |
| UnnamedSample_HQ_transcript/33818|m.10414 | UnnamedSample_HQ_transcript/33818 | Identity 0.845 too low. | 4e1619636592b75ce75a002bdd49ba88 | 536 | Pfam | PF00412 | LIM domain | 185 | 240 | 1.6E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/15847|m.5660 | UnnamedSample_HQ_transcript/15847 | Coverage 0.124 too low. | 21f7b928aed78265a840dfba3712c2ab | 1056 | Pfam | PF01171 | PP-loop family | 829 | 995 | 1.6E-12 | T | 22-09-2020 | IPR011063 | tRNA(Ile)-lysidine/2-thiocytidine synthase, N-terminal |
| UnnamedSample_HQ_transcript/84580|m.20427 | UnnamedSample_HQ_transcript/84580 | Coverage 0.990 too low. | 806bbc19fe32a13e793e8c7048469471 | 367 | Pfam | PF00026 | Eukaryotic aspartyl protease | 44 | 360 | 1.3E-43 | T | 22-09-2020 | IPR033121 | Peptidase family A1 domain |
| UnnamedSample_HQ_transcript/53346|m.14710 | UnnamedSample_HQ_transcript/53346 | Coverage 0.976 too low. | fe33c537c70e157fdec9016d5511497d | 387 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 43 | 108 | 4.6E-13 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/53346|m.14710 | UnnamedSample_HQ_transcript/53346 | Coverage 0.976 too low. | fe33c537c70e157fdec9016d5511497d | 387 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 268 | 332 | 4.7E-19 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/53346|m.14710 | UnnamedSample_HQ_transcript/53346 | Coverage 0.976 too low. | fe33c537c70e157fdec9016d5511497d | 387 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 154 | 216 | 1.2E-17 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/8370|m.3316 | UnnamedSample_HQ_transcript/8370 | Coverage 0.916 too low. | e9d7c17e79f2bae6b6a4ec63201ffe7a | 729 | Pfam | PF00412 | LIM domain | 484 | 539 | 2.4E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/81774|m.19995 | UnnamedSample_HQ_transcript/81774 | Identity 0.837 too low. | 66d657f478527e99dc744acfdadd482c | 407 | Pfam | PF00567 | Tudor domain | 75 | 183 | 2.2E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/81774|m.19995 | UnnamedSample_HQ_transcript/81774 | Identity 0.837 too low. | 66d657f478527e99dc744acfdadd482c | 407 | Pfam | PF00567 | Tudor domain | 277 | 358 | 1.6E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/45464|m.13022 | UnnamedSample_HQ_transcript/45464 | Coverage 0.427 too low. | 14c028410803ed56444f5a8393ee1f6f | 369 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 168 | 296 | 1.8E-12 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/45464|m.13022 | UnnamedSample_HQ_transcript/45464 | Coverage 0.427 too low. | 14c028410803ed56444f5a8393ee1f6f | 369 | Pfam | PF17862 | AAA+ lid domain | 52 | 88 | 4.7E-10 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/87111|m.20812 | UnnamedSample_HQ_transcript/87111 | Coverage 0.985 too low. | 5f56b659ce283f7f6784ae9434165201 | 416 | Pfam | PF00278 | Pyridoxal-dependent decarboxylase, C-terminal sheet domain | 277 | 366 | 1.5E-24 | T | 22-09-2020 | IPR022643 | Orn/DAP/Arg decarboxylase 2, C-terminal |
| UnnamedSample_HQ_transcript/87111|m.20812 | UnnamedSample_HQ_transcript/87111 | Coverage 0.985 too low. | 5f56b659ce283f7f6784ae9434165201 | 416 | Pfam | PF02784 | Pyridoxal-dependent decarboxylase, pyridoxal binding domain | 34 | 276 | 4.9E-57 | T | 22-09-2020 | IPR022644 | Orn/DAP/Arg decarboxylase 2, N-terminal |
| UnnamedSample_HQ_transcript/79959|m.19707 | UnnamedSample_HQ_transcript/79959 | Coverage 0.987 too low. | 5f56b659ce283f7f6784ae9434165201 | 416 | Pfam | PF00278 | Pyridoxal-dependent decarboxylase, C-terminal sheet domain | 277 | 366 | 1.5E-24 | T | 22-09-2020 | IPR022643 | Orn/DAP/Arg decarboxylase 2, C-terminal |
| UnnamedSample_HQ_transcript/79959|m.19707 | UnnamedSample_HQ_transcript/79959 | Coverage 0.987 too low. | 5f56b659ce283f7f6784ae9434165201 | 416 | Pfam | PF02784 | Pyridoxal-dependent decarboxylase, pyridoxal binding domain | 34 | 276 | 4.9E-57 | T | 22-09-2020 | IPR022644 | Orn/DAP/Arg decarboxylase 2, N-terminal |
| UnnamedSample_HQ_transcript/25689|m.8393 | UnnamedSample_HQ_transcript/25689 | Identity 0.931 too low. | 808545ba95221f35614166efcef32cef | 285 | Pfam | PF00408 | Phosphoglucomutase/phosphomannomutase, C-terminal domain | 193 | 259 | 2.7E-7 | T | 22-09-2020 | IPR005843 | Alpha-D-phosphohexomutase, C-terminal |
| UnnamedSample_HQ_transcript/25689|m.8393 | UnnamedSample_HQ_transcript/25689 | Identity 0.931 too low. | 808545ba95221f35614166efcef32cef | 285 | Pfam | PF02880 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain III | 30 | 143 | 6.4E-29 | T | 22-09-2020 | IPR005846 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain III |
| UnnamedSample_HQ_transcript/10953|m.4135 | UnnamedSample_HQ_transcript/10953 | Unmapped. | aaae67bef0cd336e031d81a155b4fb64 | 1113 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 747 | 1072 | 1.0E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/15021|m.5403 | UnnamedSample_HQ_transcript/15021 | Coverage 0.895 too low. | a6f9142ee8ea6afc8b7840dd75fe5f6c | 1086 | Pfam | PF00168 | C2 domain | 105 | 195 | 5.5E-19 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/15021|m.5403 | UnnamedSample_HQ_transcript/15021 | Coverage 0.895 too low. | a6f9142ee8ea6afc8b7840dd75fe5f6c | 1086 | Pfam | PF00168 | C2 domain | 933 | 1035 | 2.5E-13 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/66084|m.17229 | UnnamedSample_HQ_transcript/66084 | Coverage 0.742 too low. | 36d6367555a9fbab36bbff0ad35e4812 | 467 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 208 | 398 | 1.5E-42 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/66084|m.17229 | UnnamedSample_HQ_transcript/66084 | Coverage 0.742 too low. | 36d6367555a9fbab36bbff0ad35e4812 | 467 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 89 | 157 | 2.6E-29 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/912|m.593 | UnnamedSample_HQ_transcript/912 | Coverage 0.900 too low. | dae45281d3d26a135a36983ea3d744d1 | 625 | Pfam | PF01392 | Fz domain | 51 | 158 | 5.3E-31 | T | 22-09-2020 | IPR020067 | Frizzled domain |
| UnnamedSample_HQ_transcript/912|m.593 | UnnamedSample_HQ_transcript/912 | Coverage 0.900 too low. | dae45281d3d26a135a36983ea3d744d1 | 625 | Pfam | PF01534 | Frizzled/Smoothened family membrane region | 260 | 574 | 1.3E-131 | T | 22-09-2020 | IPR000539 | Frizzled/Smoothened, transmembrane domain |
| UnnamedSample_HQ_transcript/65210|m.17064 | UnnamedSample_HQ_transcript/65210 | Coverage 0.599 too low. | 55d4f57dbb4143fe7ebcbe0a13fb400a | 220 | Pfam | PF00271 | Helicase conserved C-terminal domain | 73 | 181 | 5.8E-32 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/71775|m.18268 | UnnamedSample_HQ_transcript/71775 | Coverage 0.541 too low. | 55d4f57dbb4143fe7ebcbe0a13fb400a | 220 | Pfam | PF00271 | Helicase conserved C-terminal domain | 73 | 181 | 5.8E-32 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/74812|m.18796 | UnnamedSample_HQ_transcript/74812 | Coverage 0.983 too low. | 64d858ca0ebe310c86f55c1f6a48bb1b | 205 | Pfam | PF04979 | Protein phosphatase inhibitor 2 (IPP-2) | 49 | 164 | 5.9E-29 | T | 22-09-2020 | IPR007062 | Protein phosphatase inhibitor 2 (IPP-2) |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
